CooperVision MiSight 1 day contact lenses

Brilliant Futures Myopia Management with MiSight® 1 day Test

Children lead active, jam-packed lives. But whether they’re playing pretend, riding bikes with their friends, or learning new things at school, myopia (shortsightedness) can make it harder for them to engage in the activities they love.

Children grow really fast and so can their shortsightedness which can lead to future eye health problems. The new Brilliant Futures™ Myopia Management Program features MiSight® 1 day soft contact lenses which go beyond traditional vision correction and can help slow shortsighted progression in children by 59% on average1 during their crucial growing years, when enjoying an active lifestyle is so important.

When wearing MiSight contact lenses, your child can experience clear vision, freedom from glasses and continue to enjoy the activities they love.1,2,3

The Brilliant Futures Myopia Management Program provides parents with the education, tools and confidence to help manage myopia in children.

 

CooperVision patient instruction leaflets
Patient instruction leaflets
product reminder
Product reminders

Unsure which products are best for you?

Take this four question quiz to discover which of our products may best fit your needs.

Find Your Lens

* Compared with a single-vision one-day lens over a three-year period.

† Over a 3 year period, MiSight® 1 day reduced myopia progression on average by 59% compared to a single vision contact lens.

‡ As reported by parents.

References:

1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567.

2. Sulley A, et al. Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. Poster presented at AAO 2019, San Francisco, Calif.

3. Chamberlain P, et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. Presentation at BCLA 2019, Manchester, England.